Global X MANAGEMENT CO LLC increased its holdings in CME Group Inc. (NASDAQ:CME) by 7.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,626 shares of the financial services provider’s stock after purchasing an additional 559 shares during the period. Global X MANAGEMENT CO LLC’s holdings in CME Group were worth $1,035,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Janus Henderson Group PLC grew its position in CME Group by 13,530.7% during the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock valued at $770,227,000 after acquiring an additional 6,104,897 shares during the period. Fiera Capital Corp grew its position in CME Group by 243.9% during the second quarter. Fiera Capital Corp now owns 1,926,918 shares of the financial services provider’s stock valued at $241,327,000 after acquiring an additional 1,366,557 shares during the period. Wells Fargo & Company MN grew its position in CME Group by 25.5% during the second quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock valued at $548,496,000 after acquiring an additional 889,217 shares during the period. BT Investment Management Ltd purchased a new stake in CME Group during the second quarter valued at about $95,104,000. Finally, Pioneer Investment Management Inc. grew its position in CME Group by 1,359.5% during the second quarter. Pioneer Investment Management Inc. now owns 697,380 shares of the financial services provider’s stock valued at $87,340,000 after acquiring an additional 649,599 shares during the period. 82.63% of the stock is owned by institutional investors and hedge funds.

CME Group Inc. (NASDAQ:CME) opened at $139.67 on Thursday. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group Inc. has a one year low of $111.19 and a one year high of $141.44. The company has a market capitalization of $47,543.92, a PE ratio of 29.33, a P/E/G ratio of 2.88 and a beta of 0.71.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The business had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter in the previous year, the firm posted $1.05 earnings per share. The company’s revenue was up 5.8% compared to the same quarter last year. analysts forecast that CME Group Inc. will post 4.78 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 1.89%. The ex-dividend date is Thursday, December 7th. CME Group’s dividend payout ratio (DPR) is 59.86%.

CME has been the subject of a number of research reports. Wells Fargo & Company boosted their price target on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 4th. Royal Bank Of Canada boosted their price target on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Barclays PLC started coverage on CME Group in a research report on Friday, September 8th. They issued an “overweight” rating and a $139.00 target price for the company. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday, September 13th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $133.00 target price on shares of CME Group in a research report on Thursday, September 21st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company’s stock. CME Group has an average rating of “Buy” and a consensus target price of $141.75.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/11/16/cme-group-inc-cme-stake-raised-by-global-x-management-co-llc.html.

In related news, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total value of $722,947.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Daniel R. Glickman sold 850 shares of the business’s stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $126.65, for a total value of $107,652.50. Following the completion of the transaction, the director now owns 13,799 shares in the company, valued at approximately $1,747,643.35. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,339 shares of company stock worth $1,548,086. Insiders own 0.57% of the company’s stock.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.